Anbio Biotechnology Class A Ordinary Shares (NNNN)
Anbio Biotechnology Class A Ordinary Shares at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Anbio Biotechnology Class A Ordinary Shares (NNNN) is a Medical - Instruments & Supplies company based in DE with a market capitalization of $1.5B. Revenue grew 19.2% year-over-year and free cash flow was negative at -$6.7M. This page tracks NNNN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
DE · 27 employees · IPO Feb 19, 2025
Valuation
Valuation & price
$26.94as of May 17, 2026· -48.3% vs 52w high
163.6
P/E ratio
Latest-FY diluted EPS
49.53
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$1.5B
Market cap
19.2%
Revenue growth (YoY)
87.2%
Gross margin
-$6.7M
Free cash flow (USD)
-$11.9M
Net debt
Net cash position
3.8%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2021 → 2025
Free cash flow by year
2021 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 20-F/A filed Apr 9, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Anbio Biotechnology Class A Ordinary Shares's market cap?
Anbio Biotechnology Class A Ordinary Shares (NNNN) has a market capitalization of $1.5B.
What is NNNN's P/E ratio?
NNNN trades at a price-to-earnings ratio of 163.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is NNNN's price-to-book (P/B) ratio?
NNNN trades at 49.53 times book value per share.
Are insiders buying NNNN stock?
SEC Form 4 filings show no open-market insider buys at Anbio Biotechnology Class A Ordinary Shares in the last 90 days (0 sells).
Same arena
Related companies in Medical - Instruments & Supplies
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.